Who Holds Cue Biopharma, Inc. (CUE)? 49 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 49 holders, $52 million in total.
Largest holders
The 49 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Bleichroeder LP | 370,682 | $12 million | New | 13F |
| Driehaus Capital Management LLC | 292,144 | $9 million | New | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 161,700 | $5 million | New | 13F |
| Ikarian Capital, LLC | 104,364 | $3 million | New | 13F |
| Tetragon Partners GP Ltd | 93,819 | $3 million | New | 13F |
| STEMPOINT CAPITAL LP | 66,995 | $2 million | New | 13F |
| BlackRock, Inc. | 57,807 | $2 million | New | 13F |
| ADAR1 Capital Management, LLC | 55,193 | $2 million | New | 13F |
| Lion Point Capital, LP | 52,928 | $2 million | New | 13F |
| Squadron Capital Management LLC | 50,000 | $2 million | New | 13F |
| DIADEMA PARTNERS LP | 48,369 | $2 million | New | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 47,824 | $2 million | New | 13F |
| BOOTHBAY FUND MANAGEMENT, LLC | 31,459 | $992,846 | New | 13F |
| UBS Group AG | 26,700 | $842,652 | New | 13F |
| CITADEL ADVISORS LLC | 25,633 | $808,977 | New | 13F |
| VANGUARD FIDUCIARY TRUST CO | 24,476 | $772,463 | New | 13F |
| Texas Capital Bank Wealth Management Services Inc | 22,881 | $722,124 | New | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 14,689 | $463,585 | New | 13F |
| Persistent Asset Partners Ltd | 12,332 | $389,198 | New | 13F |
| Robertson Stephens Wealth Management, LLC | 11,133 | $351,357 | New | 13F |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,003 | $347,255 | New | 13F |
| Seven Fleet Capital Management LP | 10,702 | $337,755 | New | 13F |
| NORTHERN TRUST CORP | 9,122 | $287,890 | New | 13F |
| ADVISORY RESEARCH INC | 8,573 | $270,564 | New | 13F |
| STIFEL FINANCIAL CORP | 8,218 | $259,360 | New | 13F |
| ANGELES WEALTH MANAGEMENT, LLC | 7,000 | $220,920 | New | 13F |
| BANK OF AMERICA CORP /DE/ | 6,929 | $218,680 | New | 13F |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2,632 | $83,066 | New | 13F |
| Vanguard Global Advisers, LLC | 1,637 | $51,664 | New | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 1,117 | $35,253 | New | 13F |
| Tower Research Capital LLC (TRC) | 869 | $27,426 | New | 13F |
| MORGAN STANLEY | 674 | $21,271 | New | 13F |
| BARCLAYS PLC | 479 | $15,117 | New | 13F |
| SBI Securities Co., Ltd. | 300 | $9,468 | New | 13F |
| Gleason Group, Inc. | 200 | $6,312 | New | 13F |
| JONES FINANCIAL COMPANIES LLLP | 213 | $5,408 | New | 13F |
| JPMORGAN CHASE & CO | 163 | $4,960 | New | 13F |
| NFSG Corp | 99 | $3,124 | New | 13F |
| Golden State Wealth Management, LLC | 66 | $2,083 | New | 13F |
| Tidemark, LLC | 50 | $1,578 | -97% | 13F |
| OSAIC HOLDINGS, INC. | 48 | $1,513 | New | 13F |
| Physician Wealth Advisors, Inc. | 33 | $1,042 | New | 13F |
| MATHER GROUP, LLC. | 33 | $1,041 | New | 13F |
| GROUP ONE TRADING LLC | 30 | $947 | New | 13F |
| WELLS FARGO & COMPANY/MN | 26 | $821 | New | 13F |
| IFP Advisors, Inc | 3 | $95 | New | 13F |
| Caitong International Asset Management Co., Ltd | 1 | $32 | New | 13F |
| CITIGROUP INC | 1 | $32 | New | 13F |
| ROYAL BANK OF CANADA | 2 | $0 | New | 13F |
Questions and answers
- How many institutions hold Cue Biopharma, Inc.?
- 49 managers reported Cue Biopharma, Inc. on Form 13F for the quarter ended 30 June 2026, against 2 the quarter before.
- Who is the largest institutional holder of Cue Biopharma, Inc.?
- Bleichroeder LP, with 370,682 shares worth $12 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Cue Biopharma, Inc. in Q2 2026?
- 48 managers reported a new position and 1 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Cue Biopharma, Inc., Q2 2026", https://app.tamarly.ai/holders/cue-biopharma, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.